The goal of this clinical trial is to learn if the OTC supplement, hydrogen water, works to treat the fatigue-related symptoms and functional limitations in adults with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). It will also examine if heart rate variability (HRV) can be used to predict who will benefit from the hydrogen water treatment. The main questions it aims to answer are:
Does the OTC supplement, hydrogen water, work to reduce the fatigue-related symptoms and improve functioning in participants who have ME/CFS?
Can HRV be used to predict who will benefit from treatment with hydrogen water?
None
None
Single group
Hydrogen water which is prepared from an OTC supplement.
Dietary supplementThe intervention is hydrogen water which is prepared from an OTC supplement. It involves measurement of heart rate variability.
Fatigue Severity Scale
This is a validated self-report measure of the effect of fatigue on functioning.
Click on the lead sponsor to view all of their trials.
